Atsushi Ishii Selected Research

Atsushi Ishii Research Topics

Disease

13	Myoclonic Epilepsies (Myoclonic Encephalopathy) 05/2022 - 09/2008
12	Epilepsy (Aura) 01/2022 - 06/2010
12	Seizures (Absence Seizure) 01/2020 - 12/2013
5	Brain Diseases (Brain Disorder) 01/2019 - 08/2014
3	Benign Neonatal Epilepsy (Benign Familial Neonatal Convulsions) 01/2019 - 03/2009
3	Febrile Seizures (Febrile Seizure) 01/2017 - 01/2015
3	Neoplasms (Cancer) 07/2010 - 07/2002
2	Partial Epilepsies (Epilepsy, Partial) 02/2019 - 01/2015
2	Adenocarcinoma 07/2010 - 10/2007
2	Carcinoma (Carcinomatosis) 10/2007 - 07/2002
1	Status Epilepticus (Complex Partial Status Epilepticus) 05/2022
1	Dizziness (Lightheadedness) 01/2022
1	Temporal Lobe Epilepsy 01/2022
1	Tourette Syndrome (Tourette's Syndrome) 01/2022
1	Paresthesia (Dysesthesia) 01/2022
1	Glut1 Deficiency Syndrome 10/2020
1	Myoclonus (Nocturnal Myoclonus) 10/2020
1	Nervous System Diseases (Neurological Disorders) 10/2020
1	Spasm (Spasms) 01/2020
1	Infantile Spasms (West Syndrome) 01/2020
1	Drug Resistant Epilepsy 01/2020
1	Cardiac Arrhythmias (Arrythmia) 02/2019
1	Ventricular Tachycardia 02/2019
1	Paralysis (Palsy) 03/2018
1	Atrophy 05/2017
1	Intellectual Disability (Idiocy) 01/2017
1	Alternating hemiplegia of childhood 01/2016
1	Dystonia (Limb Dystonia) 01/2016
1	Fever (Fevers) 11/2015
1	Asthma (Bronchial Asthma) 11/2015
1	Body Weight (Weight, Body) 02/2015
1	Epileptic Syndromes 05/2014
1	Fabry Disease (Fabry's Disease) 08/2013
1	Pancreatitis 04/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2013

Drug/Important Bio-Agent (IBA)

7	Anticonvulsants (Antiepileptic Drugs)IBA 05/2022 - 12/2013
5	Sodium Channels (Sodium Channel)IBA 01/2016 - 09/2008
3	Phenobarbital (Luminal)FDA Link 05/2022 - 08/2014
3	NucleotidesIBA 11/2019 - 01/2015
3	Carbamazepine (Tegretol)FDA LinkGeneric 01/2017 - 01/2016
3	Messenger RNA (mRNA)IBA 10/2007 - 02/2002
2	Midazolam (Versed)FDA LinkGeneric 05/2022 - 08/2014
2	BenzodiazepinesIBA 05/2022 - 08/2014
2	perampanelIBA 10/2019 - 01/2019
2	PotassiumIBA 02/2019 - 03/2009
2	Voltage-Gated Sodium ChannelsIBA 01/2017 - 01/2017
2	human PRRT2 proteinIBA 01/2016 - 01/2015
2	Theophylline (Theon)FDA LinkGeneric 11/2015 - 05/2015
2	GangliosidesIBA 10/2007 - 07/2002
2	haematoside synthetaseIBA 10/2007 - 02/2002
2	G(M3) GangliosideIBA 10/2007 - 02/2002
1	Therapeutic UsesIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 10/2020
1	AntibodiesIBA 10/2020
1	AutoantibodiesIBA 10/2020
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	SodiumIBA 02/2019
1	Quinidine (Chinidin)FDA LinkGeneric 02/2019
1	Potassium Channels (Potassium Channel)IBA 01/2019
1	FlunarizineIBA 03/2018
1	Adenosine Triphosphatases (ATPase)IBA 05/2017
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2017
1	Topiramate (Topamax)FDA LinkGeneric 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2016
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	triphosphoric acid (triphosphate)IBA 01/2016
1	ezogabine (retigabine)IBA 01/2016
1	Kainic Acid (Kainate)IBA 01/2016
1	Amino Acids FDA Link 11/2015
1	beta-Aminoethyl Isothiourea (AET)IBA 05/2015
1	Clobazam (HR 376)IBA 02/2015
1	Cytochrome P-450 CYP2C19IBA 02/2015
1	Valproic Acid (Depakote)FDA LinkGeneric 02/2015
1	N-desmethylclobazam (norclobazam)IBA 02/2015
1	AcidsIBA 02/2015
1	stiripentolIBA 02/2015
1	BarbituratesIBA 08/2014
1	Genetic Markers (Genetic Marker)IBA 06/2014
1	Ion Channels (Ion Channel)IBA 05/2014
1	Nonsense Codon (Nonsense Mutation)IBA 03/2014
1	Mutant Proteins (Protein, Mutant)IBA 03/2014
1	Clorazepate Dipotassium (Tranxene)FDA LinkGeneric 12/2013
1	GalactosidasesIBA 08/2013
1	oxidized low density lipoproteinIBA 02/2013
1	Proteins (Proteins, Gene)FDA Link 08/2010
1	Indicators and Reagents (Reagents)IBA 07/2010
1	PAsp(DET)IBA 07/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2010
1	Small Interfering RNA (siRNA)IBA 07/2010
1	GABA Receptors (GABA Receptor)IBA 06/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2007
1	MucinsIBA 10/2007

Therapy/Procedure

7	Therapeutics 01/2020 - 07/2002
2	Vagus Nerve Stimulation 01/2017 - 12/2013
1	Deep Brain Stimulation 01/2022
1	Investigational Therapies (Experimental Therapy) 01/2016
1	Intraperitoneal Injections 01/2016